1Lamm DL.Prophylaxis for recurrent transitional cell carcinoma.Urology,1991,37(suppl5):21.
2Mc Cabe RP,Lamm LD,Hasrel MV,et al.A diagnosticprognostic test for biadder cancer using a monoclonal antibodybased enzyme-linked immunoassay for detection of urinary fibrinogen products.Cancer Res,1984,44:5886-5892.
8Setsuko K.Rapid uptake by cultured tumor cells and intracellular behavior of 4'-O-tetrahydropyranyladrimycin.J Antibiot,1983,36:312.
9Oguhara M.Retrospective study of prophylactic intravesical therapy on primary superficial bladder cancer.Japan J Cancer Chemother,1996,23:465-470.
二级参考文献12
1韩瑞发，中华泌尿外科杂志，1994年，15卷，425页
2张广健，中华泌尿外科杂志，1994年，15卷，419页
3金冬雁，分子克隆实验指南（第2版），1992年
4Kurbacher C M, Cree I A, Bruckner H W, et al. Use of an ex vivo ATP luminescence assay to direct chemotherapy for recurrent ovarian cancer[J]. Anticancer Drugs, 1998,9(1):51-57.
5Uchibayashi T, Egawa M, Hisazumi H, et al. In vitro chemosensitivity test for human genitourinary tumors using collagen gel matrix[J]. Eur Urol, 1993,24(2):267-270.
6Petty R D, Sutherland L A, Hunter E M, et al. Comparison of MTT and ATP-based assays for the measurement of viable cell number [J]. J Biolumin Chemilumin, 1995,10(1):29-34.
7Sharma S, Neale M H, Di Nicolantoniol F, et al. Outcome of ATP-based tumor chemosensitivity assay directed chemotherapy in heavily pre-treated recurrent ovarian carcinoma [J]. BMC Cancer, 2003,3(1):19.
8Koechli O R, Avner B P, Sevin B U, et al. Application of the adenosine triphosphate-cell viability assay in human breast cancer chemosensitivity testing: a report on the first results [J]. J Surg Oncol, 1993,54(2):119-125.
9Yoshitada Ohi,Hiroyuki Ohmori,Tsutomu Shirahama,Motoshi Kawahara,Yosuke Matsumura,Tomoyasu Tsushima,Yasuo Ohashi. Intravesical instillation of Adriamycin in the presence or absence of verapamil for the treatment of superficial bladder cancer: preliminary report of a collaborative study[J] 1992,Cancer Chemotherapy and Pharmacology(1):S50～S54
